Linna Ding

6.9k total citations · 1 hit paper
33 papers, 2.2k citations indexed

About

Linna Ding is a scholar working on Immunology, Pulmonary and Respiratory Medicine and Rheumatology. According to data from OpenAlex, Linna Ding has authored 33 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Immunology, 7 papers in Pulmonary and Respiratory Medicine and 7 papers in Rheumatology. Recurrent topics in Linna Ding's work include Immune Cell Function and Interaction (10 papers), Immunotherapy and Immune Responses (10 papers) and T-cell and B-cell Immunology (10 papers). Linna Ding is often cited by papers focused on Immune Cell Function and Interaction (10 papers), Immunotherapy and Immune Responses (10 papers) and T-cell and B-cell Immunology (10 papers). Linna Ding collaborates with scholars based in United States, Netherlands and Lebanon. Linna Ding's co-authors include Ethan M. Shevach, R N Germain, Peter S. Linsley, Long Huang, Robert Spiera, Philip Seo, Ulrich Specks, John H. Stone, Gary S. Hoffman and Carol A. Langford and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and Journal of the American Society of Nephrology.

In The Last Decade

Linna Ding

32 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression.

1993 717 citations Linna Ding, Peter S. Linsley et al. The Journal of Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Linna Ding United States	18	1.2k	386	270	268	266	33	2.2k
Massimo Fiorilli Italy	28	1.1k 0.9×	219 0.6×	270 1.0×	328 1.2×	468 1.8×	118	2.5k
Roman Krzysiek France	23	1.6k 1.3×	221 0.6×	177 0.7×	191 0.7×	254 1.0×	46	2.4k
Bruce Allen Bach United States	25	1.1k 0.9×	600 1.6×	107 0.4×	292 1.1×	499 1.9×	57	2.7k
Fabio Almerigogna Italy	23	1.8k 1.5×	117 0.3×	145 0.5×	187 0.7×	364 1.4×	61	2.9k
Makoto Hirokawa Japan	28	983 0.8×	292 0.8×	139 0.5×	330 1.2×	363 1.4×	121	2.6k
Yui‐Hsi Wang United States	26	2.6k 2.1×	153 0.4×	189 0.7×	204 0.8×	321 1.2×	38	3.7k
Edward J Carr United Kingdom	21	1.1k 0.9×	202 0.5×	341 1.3×	190 0.7×	366 1.4×	30	1.9k
A N Theofilopoulos United States	22	1.4k 1.1×	209 0.5×	180 0.7×	380 1.4×	251 0.9×	36	2.0k
R J Levinsky United Kingdom	21	1.0k 0.8×	152 0.4×	274 1.0×	222 0.8×	292 1.1×	35	2.0k
L.U. Lamm Denmark	23	1.8k 1.4×	214 0.6×	322 1.2×	259 1.0×	496 1.9×	80	3.0k

Countries citing papers authored by Linna Ding

Since Specialization

Citations

This map shows the geographic impact of Linna Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linna Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linna Ding more than expected).

Fields of papers citing papers by Linna Ding

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linna Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linna Ding. The network helps show where Linna Ding may publish in the future.

Co-authorship network of co-authors of Linna Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Linna Ding. A scholar is included among the top collaborators of Linna Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linna Ding. Linna Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Qingyang, et al.. (2025). Micropolymorphism outside the peptide-binding groove of human leukocyte antigen (HLA)-C*14 modulates structural stability and shapes immune responses. International Journal of Biological Macromolecules. 309(Pt 1). 142772–142772.

Ding, Linna, et al.. (2023). A Research on Preparation and Performance of Volcanogenic Sand Concrete from the Philippines. Materials. 16(6). 2306–2306. 1 indexed citations

Glatigny, Simon, Barbara Höllbacher, Samantha Motley, et al.. (2019). Abatacept Targets T Follicular Helper and Regulatory T Cells, Disrupting Molecular Pathways That Regulate Their Proliferation and Maintenance. The Journal of Immunology. 202(5). 1373–1382. 45 indexed citations

Rhee, Rennie L., John C. Davis, Linna Ding, et al.. (2018). The Utility of Urinalysis in Determining the Risk of Renal Relapse in ANCA-Associated Vasculitis. Clinical Journal of the American Society of Nephrology. 13(2). 251–257. 46 indexed citations

Khoury, Samia J., James Rochon, Linna Ding, et al.. (2016). ACCLAIM: A randomized trial of abatacept (CTLA4-Ig) for relapsing-remitting multiple sclerosis. Multiple Sclerosis Journal. 23(5). 686–695. 42 indexed citations

Gitelman, Stephen E., Peter A. Gottlieb, Eric I. Felner, et al.. (2016). Antithymocyte globulin therapy for patients with recent-onset type 1 diabetes: 2 year results of a randomised trial. Diabetologia. 59(6). 1153–1161. 65 indexed citations

Unizony, Sebastian, Miguel Villarreal, Eli M. Miloslavsky, et al.. (2015). Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type. Annals of the Rheumatic Diseases. 75(6). 1166–1169. 173 indexed citations

Miloslavsky, Eli M., Ulrich Specks, Peter A. Merkel, et al.. (2015). Outcomes of Nonsevere Relapses in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis Treated With Glucocorticoids. Arthritis & Rheumatology. 67(6). 1629–1636. 39 indexed citations

Miloslavsky, Eli M., Ulrich Specks, Peter A. Margolis, et al.. (2013). Efficacy Of Glucocorticoids To Treat Limited Flares In ANCA-Associated Vasculitis. Data Archiving and Networked Services (DANS). 1 indexed citations

10.

Gitelman, Stephen E., Peter A. Gottlieb, Mark Rigby, et al.. (2013). Antithymocyte globulin treatment for patients with recent-onset type 1 diabetes: 12-month results of a randomised, placebo-controlled, phase 2 trial. The Lancet Diabetes & Endocrinology. 1(4). 306–316. 97 indexed citations

11.

Machuca, Ana, Linna Ding, Rolf E. Taffs, et al.. (2004). HIV Type 2 Primary Isolates Induce a Lower Degree of Apoptosis " in Vitro " Compared with HIV Type 1 Primary Isolates. AIDS Research and Human Retroviruses. 20(5). 507–512. 12 indexed citations

12.

Zhang, Mingjie, Xingxiang Li, Xiaowu Pang, et al.. (2002). Bcl-2 Upregulation by HIV-1 Tat during Infection of Primary Human Macrophages in Culture. Journal of Biomedical Science. 9(2). 133–139. 4 indexed citations

13.

Zhang, Mingjie, Xingxiang Li, Xiaowu Pang, et al.. (2001). Identification of a potential HIV-induced source of bystander-mediated apoptosis in T cells: Upregulation of TRAIL in primary human macrophages by HIV-1 tat. Journal of Biomedical Science. 8(3). 290–296. 82 indexed citations

14.

Ding, Linna & E M Shevach. (2001). Inhibition of the function of the FcγRIIB by a monoclonal antibody to thymic shared antigen‐1, a Ly‐6 family antigen. Immunology. 104(1). 28–36. 5 indexed citations

15.

Ding, Linna & Ethan M. Shevach. (1998). Differential Effects of CD28 Engagement and IL-12 on T Cell Activation by Altered Peptide Ligands. The Journal of Immunology. 161(12). 6614–6621. 15 indexed citations

16.

Ding, Linna & Ethan M. Shevach. (1996). Activated B cells express CD28/B7-independent costimulatory activity. The Journal of Immunology. 157(4). 1389–1396. 21 indexed citations

17.

Ding, Linna, Jonathan M. Green, Craig B. Thompson, & Ethan M. Shevach. (1995). B7/CD28-dependent and -independent induction of CD40 ligand expression. The Journal of Immunology. 155(11). 5124–5132. 82 indexed citations

18.

Ding, Linna & Ethan M. Shevach. (1994). Activation of CD4⁺ T cells by delivery of the B7 costimulatory signal on bystander antigen‐presenting cells (trans‐costimulation). European Journal of Immunology. 24(4). 859–866. 77 indexed citations

19.

Ding, Linna, Peter S. Linsley, Long Huang, R N Germain, & Ethan M. Shevach. (1993). IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression.. The Journal of Immunology. 151(3). 1224–1234. 717 indexed citations breakdown →

20.

Ding, Linna & Ethan M. Shevach. (1992). IL-10 inhibits mitogen-induced T cell proliferation by selectively inhibiting macrophage costimulatory function. The Journal of Immunology. 148(10). 3133–3139. 322 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact